SCHEMBL3973836

SCHEMBL3973836

NC(=O)c1cccc(-c2ccccc2)c1OCCCl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.54
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
HNF4A P41235 1/20 0.41
LMNA P02545 3/20 0.40
KDM4E B2RXH2 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
ALDH1A1 P00352 2/20 0.39
PARP1 P09874 1/20 0.39
MAPK1 P28482 2/20 0.39
TP53 P04637 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
HTT P42858 3/20 0.38
MAPT P10636 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
IKBKB O14920 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975515 0.86 BCAT2 (0.54) BCAT2L3MBTL1TDP1HNF4ALMNA
SCHEMBL3981622 0.83 BCAT2 (0.44) BCAT2L3MBTL1TDP1LMNAKDM4E
SCHEMBL5504641 0.82 BCAT2 (0.57) BCAT2L3MBTL1TDP1HNF4ALMNA
SCHEMBL3979295 0.82 BCAT2 (0.43) BCAT2L3MBTL1TDP1LMNAKDM4E
SCHEMBL1667777 0.81 BCAT2 (0.56) BCAT2KDM4EPARP1HTT
SCHEMBL11340527 0.77 HNF4A (0.54) BCAT2L3MBTL1TDP1HNF4ALMNA
SCHEMBL30504310 0.77 BCAT2 (0.62) BCAT2L3MBTL1HNF4AKDM4ERAB9A
Hydrochloric Acid SCHEMBL30628503 0.76 BCAT2 (0.61) BCAT2L3MBTL1HNF4AKDM4ERAB9A
Hydrochloric Acid SCHEMBL30504328 0.76 BCAT2 (0.61) BCAT2L3MBTL1HNF4AKDM4ERAB9A
SCHEMBL28081509 0.76 BCAT2 (0.61) BCAT2HNF4AKDM4ERAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054383-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-05-06 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed